Join
Live feed
·
INSIDERFilingvia Quantisnow
Inovio Pharmaceuticals Inc. logo

Chief Medical Officer Sumner Michael John covered exercise/tax liability with 3,903 shares and converted options into 16,560 shares, increasing direct ownership by 71% to 30,507 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INO (Inovio Pharmaceuticals Inc.) and more on Quantisnow.